Suppression of virus-specific antibody production by CD8⁺ class I-restricted antiviral cytotoxic T cells in vivo

Agriculture & Biology

• Lymphocytic choriomeningitis mammarenavirus 100%
• antibody formation 58%
• T-lymphocytes 54%
• viruses 38%
• genetically modified organisms 26%
• cytotoxic T-lymphocytes 20%
• B-lymphocytes 19%
• mice 14%
• receptors 10%
• spleen 8%
• immunopathology 7%
• infection 7%
• antigen presentation 7%
• kinetics 6%
• immunosuppression 5%
• point mutation 5%
• dosage 5%
• transgenes 4%
• macrophages 4%
• monoclonal antibodies 4%
• glycoproteins 4%
• peptides 3%
• mutants 2%
• tissues 2%

Medicine & Life Sciences

• Lymphocytic choriomeningitis virus 82%
• Antibody Formation 53%
• Antiviral Agents 50%
• Viruses 39%
• T-Lymphocytes 36%
• Cytotoxic T-Lymphocytes 15%
• B-Lymphocytes 15%
• T-Cell Antigen Receptor 15%
• Transgenic Mice 13%
• peptide 32 8%
• Spleen 7%
• Kinetics 7%
• Infections 7%
• Adoptive Transfer 5%
• Antigen Presentation 5%
• Lymphoid Tissue 5%
• Transgenes 4%
• Point Mutation 4%
• Immunosuppression 4%
• Glycoproteins 4%
• Monoclonal Antibodies 3%
• Macrophages 3%
• Therapeutics 0%